Zhen Huang

Director/Miembro de la Junta en WALVAX BIOTECHNOLOGY CO., LTD. .

Fortuna: 57 M $ al 31/05/2024

61 años

Health Technology

Perfil

Zhen Huang currently works at Walvax Biotechnology Co., Ltd., as Vice Chairman from 2019, Shanghai Zerun Biotechnology Co., Ltd., as Director, and Yuxi Walvax Biotechnology Co., Ltd., as President.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
WALVAX BIOTECHNOLOGY CO., LTD. CLASS A 1.14%	30/06/2023	17 698 729 ( 1.14% )	33 M $	31/05/2024
WALVAX BIOTECHNOLOGY CO., LTD. 28.09%	30/09/2023	13 274 047 ( 28.09% )	24 M $	31/05/2024

Cargos activos de Zhen Huang

Empresas	Cargo	Inicio
WALVAX BIOTECHNOLOGY CO., LTD.	Director/Miembro de la Junta	22/08/2019
Yuxi Walvax Biotechnology Co., Ltd.	Presidente	-
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Director/Miembro de la Junta	-

Todos los cargos activos de Zhen Huang

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Zhen Huang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
WALVAX BIOTECHNOLOGY CO., LTD.	Health Technology

Empresas privadas	2
Yuxi Walvax Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.	Health Technology